메뉴 건너뛰기




Volumn 60, Issue 6, 2013, Pages

An association of craniopharyngioma in Turner syndrome

Author keywords

Craniopharyngioma; Hypopituitarism; Rathke's pouch; Turner syndrome

Indexed keywords

DESMOPRESSIN; GROWTH HORMONE; HYDROCORTISONE; THYROXINE;

EID: 84876438495     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24411     Document Type: Article
Times cited : (6)

References (9)
  • 1
    • 77958534847 scopus 로고    scopus 로고
    • Childhood craniopharyngioma-Current concepts in diagnosis, therapy and follow-up
    • Müller HL. Childhood craniopharyngioma-Current concepts in diagnosis, therapy and follow-up. Nature Rev Endocrinol 2010; 6: 609-618.
    • (2010) Nature Rev Endocrinol , vol.6 , pp. 609-618
    • Müller, H.L.1
  • 2
    • 24944440407 scopus 로고    scopus 로고
    • Endocrine manifestations of craniopharyngioma
    • Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 2005; 21: 640-648.
    • (2005) Childs Nerv Syst , vol.21 , pp. 640-648
    • Halac, I.1    Zimmerman, D.2
  • 3
    • 33744811403 scopus 로고    scopus 로고
    • Optimising management in Turner syndrome: From infancy to adult transfer
    • Donaldson MD, Gault EJ, Tan KW. et al. Optimising management in Turner syndrome: From infancy to adult transfer. Arch Dis Child 2006; 91: 513-520.
    • (2006) Arch Dis Child , vol.91 , pp. 513-520
    • Donaldson, M.D.1    Gault, E.J.2    Tan, K.W.3
  • 4
    • 84876425790 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence. Human growth hormone for the treatment of growth failure in children (review). [NICE technology appraisal guidance 188]. London: National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence (2010). Human growth hormone for the treatment of growth failure in children (review). [NICE technology appraisal guidance 188]. London: National Institute for Health and Clinical Excellence (www.nice.org.uk).
    • (2010)
  • 5
    • 79951797804 scopus 로고    scopus 로고
    • Short stature due to SHOX deficiency: Genotype, phenotype, and therapy
    • Bunin GR, Surawicz TS, Witman PA. et al. Short stature due to SHOX deficiency: Genotype, phenotype, and therapy. Horm Res Paediatr 2011; 75: 81-89.
    • (2011) Horm Res Paediatr , vol.75 , pp. 81-89
    • Bunin, G.R.1    Surawicz, T.S.2    Witman, P.A.3
  • 6
    • 84876428780 scopus 로고    scopus 로고
    • Pfizer Inc., Pfizer Endocrine Care, KIGS/KIMS/ACROSTUDY Medical Outcomes SE-191 90 Sollentuna, Sweden. Email: sofia.fristamatpfizer.com
    • Pfizer Inc., Pfizer Endocrine Care, KIGS/KIMS/ACROSTUDY Medical Outcomes SE-191 90 Sollentuna, Sweden. Email: sofia.fristamatpfizer.com https://www.medicaloutcomes.pfizer.com/MedicalOutcome.aspx?id=3061
  • 7
    • 84876422977 scopus 로고    scopus 로고
    • Margaretha Lindell, KIGS Project Director, Pfizer Health AB, Endocrine Care, KIGS/KIMS/ACROSTUDY Medical Outcomes, Sollentuna, Sweden.
    • Margaretha Lindell, KIGS Project Director, Pfizer Health AB, Endocrine Care, KIGS/KIMS/ACROSTUDY Medical Outcomes, Sollentuna, Sweden.
  • 9
    • 77958541304 scopus 로고    scopus 로고
    • Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children
    • Rohrer TR, Langer T, Grabenbauer GG, et al. Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children. J Pediatr Endocrinol Metab 2010; 23: 935-942.
    • (2010) J Pediatr Endocrinol Metab , vol.23 , pp. 935-942
    • Rohrer, T.R.1    Langer, T.2    Grabenbauer, G.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.